The Stage Classification of Lung Cancer

Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
      The current Lung Cancer Stage Classification system is the seventh edition, which took effect in January 2010. This article reviews the definitions for the TNM descriptors and the stage grouping in this system.
      To read this article in full you will need to make a payment
      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lewis SZ
        • Diekemper R
        • Addrizzo-Harris DJ
        Methodology for development of guidelines for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
        Chest. 2013; 143: 41S-50S
        • Groome PA
        • Bolejack V
        • Crowley JJ
        • IASLC International Staging Committee
        • Cancer Research and Biostatistics
        • Observers to the Committee; Participating Institutions
        • et al.
        The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours.
        J Thorac Oncol. 2007; 2: 694-705
        • Union Internationale Contre le Cancer
        TNM Classification of Malignant Tumors. 7th ed. Wiley-Blackwell, Hoboken, NJ2009
        • American Joint Committee on Cancer
        AJCC Cancer Staging. Manual. 7th ed. Springer, New York, NY2009
      1. Wittekind C TNM Supplement: A Commentary on Uniform Use. 4th ed. John Wiley & Sons, London, England2012
      2. Goldstraw P IASLC Staging Manual in Thoracic Oncology. Editorial Rx Press, Orange Park, FL2009
        • Rami-Porta R
        • Ball D
        • Crowley J
        • International Staging Committee
        • Cancer Research and Biostatistics
        • Observers to the Committee
        • Participating Institutions
        • et al.
        The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer.
        J Thorac Oncol. 2007; 2: 593-602
        • Rusch VW
        • Crowley J
        • Giroux DJ
        • International Association for the Study of Lung Cancer International Staging Committee
        • Cancer Research and Biostatistics
        • Observers to the Committee
        • Participating Institutions
        • et al.
        The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer.
        J Thorac Oncol. 2007; 2: 603-612
        • Postmus PE
        • Brambilla E
        • Chansky K
        • International Association for the Study of Lung Cancer International Staging Committee
        • Cancer Research and Biostatistics
        • Observers to the Committee
        • Participating Institutions
        • et al.
        The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer.
        J Thorac Oncol. 2007; 2: 686-693
        • Goldstraw P
        • Crowley J
        • Chansky K
        • International Association for the Study of Lung Cancer International Staging Committee
        • Participating Institutions
        • et al.
        The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours.
        J Thorac Oncol. 2007; 2: 706-714
        • Shepherd FA
        • Crowley J
        • Van Houtte P
        • International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions
        • et al.
        The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.
        J Thorac Oncol. 2007; 2: 1067-1077
        • Travis WD
        • Giroux DJ
        • Chansky K
        • International Staging Committee and Participating Institutions
        • et al.
        The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer.
        J Thorac Oncol. 2008; 3: 1213-1223
        • Detterbeck FC
        • Boffa DJ
        • Tanoue LT
        The new lung cancer staging system.
        Chest. 2009; 136: 260-271
        • Detterbeck FC
        • Boffa DJ
        • Tanoue LT
        • Wilson LD
        Details and difficulties regarding the new lung cancer staging system.
        Chest. 2010; 137: 1172-1180
        • Hsu P-K
        • Huang H-C
        • Hsieh C-C
        • et al.
        Effect of formalin fixation on tumor size determination in stage I non-small cell lung cancer.
        Ann Thorac Surg. 2007; 84: 1825-1829
        • Yim J
        • Zhu L-C
        • Chiriboga L
        • Watson HN
        • Goldberg JD
        • Moreira AL
        Histologic features are important prognostic indicators in early stages lung adenocarcinomas.
        Mod Pathol. 2007; 20: 233-241
        • Suzuki K
        • Yokose T
        • Yoshida J
        • et al.
        Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung.
        Ann Thorac Surg. 2000; 69: 893-897
        • Maeshima AM
        • Niki T
        • Maeshima A
        • Yamada T
        • Kondo H
        • Matsuno Y
        Modified scar grade: a prognostic indicator in small peripheral lung adenocarcinoma.
        Cancer. 2002; 95: 2546-2554
      3. Travis W, Brambilla E, Noguchi M, et al. The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification. Paper presented at: 13th World Conference on Lung Cancer; August 4, 2009; San Francisco, CA.

        • Yokose T
        • Suzuki K
        • Nagai K
        • Nishiwaki Y
        • Sasaki S
        • Ochiai A
        Favorable and unfavorable morphological prognostic factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter.
        Lung Cancer. 2000; 29: 179-188
        • Kerr KM
        Pulmonary adenocarcinomas: classification and reporting.
        Histopathology. 2009; 54: 12-27
        • Yoshizawa A
        • Motoi N
        • Riely GJ
        • et al.
        Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.
        Mod Pathol. 2011; 24: 653-664
        • Travis WDMD
        • Brambilla EMD
        • Rami-Porta RMD
        • International Staging Committee
        • et al.
        Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer.
        J Thorac Oncol. 2008; 3: 1384-1390
        • Rusch V
        • Asamura H
        • Watanabe H
        • Giroux DJ
        • Rami-Porta R
        • Goldstraw P
        • Members of IASLC Staging Committee
        The IASLC Lung Cancer Staging Project: a proposal for a new international lymph node map in the forthcoming 7th edition of the TNM classification for lung cancer.
        J Thorac Oncol. 2009; 4: 568-577
        • Detterbeck F
        • Jantz M
        • Wallace M
        • Vansteenkiste J
        • Silvestri GA
        • American College of Chest Physicians
        Invasive mediastinal staging of lung cancer: ACCP evidence based clinical practice guidelines (2nd edition).
        Chest. 2007; 132: 202S-220S
        • Lardinois D
        • De Leyn P
        • Van Schil P
        • et al.
        ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer.
        Eur J Cardiothorac Surg. 2006; 30: 787-792
        • Liptay MJMD
        • D'amico TAMD
        • Nwogu CMD
        • Thoracic Surgery Subcommittee of the Cancer and Leukemia Group B
        • et al.
        Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial.
        J Thorac Oncol. 2009; 4: 198-202
        • Rzyman W
        • Hagen OM
        • Dziadziuszko R
        • et al.
        Intraoperative, radio-guided sentinel lymph node mapping in 110 nonsmall cell lung cancer patients.
        Ann Thorac Surg. 2006; 82: 237-242
        • Ono T
        • Minamiya Y
        • Ito M
        • et al.
        Sentinel node mapping and micrometastasis in patients with clinical stage IA non-small cell lung cancer.
        Interact Cardiovasc Thorac Surg. 2009; 9: 659-661
        • Kim AW
        • Johnson KM
        • Detterbeck FC
        The lung cancer stage page: there when you need it.
        Chest. 2012; 141 (staginglungcancer.org): 581-586
        • Gould MK
        • Donington J
        • Lynch WR
        • et al.
        Evaluation of individuals with pulmonary nodules: when is it lung cancer? diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
        Chest. 2013; 143: e93S-e120S
        • Keogan MT
        • Tung KT
        • Kaplan DK
        • Goldstraw PJ
        • Hansell DM
        The significance of pulmonary nodules detected on CT staging for lung cancer.
        Clin Radiol. 1993; 48: 94-96
        • Kunitoh H
        • Eguchi K
        • Yamada K
        • et al.
        Intrapulmonary sublesions detected before surgery in patients with lung cancer.
        Cancer. 1992; 70: 1876-1879
        • Shen KR
        • Meyers BF
        • Larner JM
        • Jones DR
        • American College of Chest Physicians
        Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
        Chest. 2007; 132: 290S-305S
        • Cerfolio RJ
        • Bryant AS
        Is palpation of the nonresected pulmonary lobe(s) required for patients with non-small cell lung cancer? A prospective study.
        J Thorac Cardiovasc Surg. 2008; 135: 261-268
        • Swensen SJ
        • Silverstein MD
        • Edell ES
        • et al.
        Solitary pulmonary nodules: clinical prediction model versus physicians.
        Mayo Clin Proc. 1999; 74: 319-329
        • Antakli T
        • Schaefer RF
        • Rutherford JE
        • Read RC
        Second primary lung cancer.
        Ann Thorac Surg. 1995; 59: 863-866
        • Thomas Jr, PA
        • Rubinstein L
        • The Lung Cancer Study Group
        Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer.
        J Thorac Cardiovasc Surg. 1993; 106: 1053-1058
        • Pastorino U
        • Infante M
        • Maioli M
        • et al.
        Adjuvant treatment of stage I lung cancer with high-dose vitamin A.
        J Clin Oncol. 1993; 11: 1216-1222
        • Martini N
        • Bains MS
        • Burt ME
        • et al.
        Incidence of local recurrence and second primary tumors in resected stage I lung cancer.
        J Thorac Cardiovasc Surg. 1995; 109: 120-129
        • Ribet M
        • Dambron P
        Multiple primary lung cancers.
        Eur J Cardiothorac Surg. 1995; 9: 231-236
        • Van Meerbeeck J
        • Weyler J
        • Thibaut A
        • et al.
        Second primary lung cancer in Flanders: frequency, clinical presentation, treatment and prognosis.
        Lung Cancer. 1996; 15: 281-295
        • Levi F
        • Randimbison L
        • Te V-C
        • La Vecchia C
        Second primary cancers in patients with lung carcinoma.
        Cancer. 1999; 86: 186-190
        • Tockman MS
        • Mulshine JL
        • Piantadosi S
        • et al.
        Prospective detection of preclinical lung cancer: results from two studies of heterogeneous ribonucleoprotein A2/B1 overexpression.
        Clin Cancer Res. 1997; 3: 2237-2246
        • Ginsberg RJ
        • Rubinstein LV
        • Lung Cancer Study Group
        Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer.
        Ann Thorac Surg. 1995; 60: 615-622
        • Pairolero PC
        • Williams DE
        • Bergstralh EJ
        • Piehler JM
        • Bernatz PE
        • Payne WS
        Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease.
        Ann Thorac Surg. 1984; 38: 331-338
        • Saito Y
        • Sato M
        • Sagawa M
        • et al.
        Multicentricity in resected occult bronchogenic squamous cell carcinoma.
        Ann Thorac Surg. 1994; 57: 1200-1205
        • Martini N
        • Melamed MR
        Multiple primary lung cancers.
        J Thorac Cardiovasc Surg. 1975; 70: 606-612
        • Detterbeck FC
        • Jones DR
        • Kernstine KH
        • Naunheim KS
        • American College of Physicians
        Lung cancer. Special treatment issues.
        Chest. 2003; 123: 244S-258S
        • van Bodegom PC
        • Wagenaar SS
        • Corrin B
        • Baak JP
        • Berkel J
        • Vanderschueren RG
        Second primary lung cancer: importance of long term follow up.
        Thorax. 1989; 44: 788-793
        • Mathisen DJ
        • Jensik RJ
        • Faber LP
        • Kittle CF
        Survival following resection for second and third primary lung cancers.
        J Thorac Cardiovasc Surg. 1984; 88: 502-510
        • Deschamps C
        • Pairolero PC
        • Trastek VF
        • Payne WS
        Multiple primary lung cancers. Results of surgical treatment.
        J Thorac Cardiovasc Surg. 1990; 99: 769-777
        • Rosengart TK
        • Martini N
        • Ghosn P
        • Burt M
        Multiple primary lung carcinomas: prognosis and treatment.
        Ann Thorac Surg. 1991; 52: 773-778
        • Verhagen AFTM
        • Tavilla G
        • van de Wal HJCM
        • Cox AL
        • Lacquet LK
        Multiple primary lung cancers.
        Thorac Cardiovasc Surg. 1994; 42: 40-44
        • Adebonojo SA
        • Moritz DM
        • Danby CA
        The results of modern surgical therapy for multiple primary lung cancers.
        Chest. 1997; 112: 693-701
        • Okada M
        • Tsubota N
        • Yoshimura M
        • Miyamoto Y
        Operative approach for multiple primary lung carcinomas.
        J Thorac Cardiovasc Surg. 1998; 115: 836-840
        • Wu SC
        • Lin ZQ
        • Xu CW
        • Koo KS
        • Huang OL
        • Xie DQ
        Multiple primary lung cancers.
        Chest. 1987; 92: 892-896
        • De Leyn P
        • Moons J
        • Vansteenkiste J
        • et al.
        Survival after resection of synchronous bilateral lung cancer.
        Eur J Cardiothorac Surg. 2008; 34: 1215-1222
        • Lee JG
        • Lee CY
        • Kim DJ
        • Chung KY
        • Park IK
        Non-small cell lung cancer with ipsilateral pulmonary metastases: prognosis analysis and staging assessment.
        Eur J Cardiothorac Surg. 2008; 33: 480-484
        • Riquet M
        • Cazes A
        • Pfeuty K
        • et al.
        Multiple lung cancers prognosis: what about histology?.
        Ann Thorac Surg. 2008; 86: 921-926
        • Rostad H
        • Strand TE
        • Naalsund A
        • Norstein J
        Resected synchronous primary malignant lung tumors: a population-based study.
        Ann Thorac Surg. 2008; 85: 204-209
        • Battafarano RJ
        • Meyers BF
        • Guthrie TJ
        • Cooper JD
        • Patterson GA
        Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival.
        Ann Thorac Surg. 2002; 74: 988-993
        • Detterbeck FC
        • Jones DR
        • Funkhouser WK
        Satellite nodules and multiple primary cancers.
        in: Detterbeck FC Rivera MP Socinski Jr, MA Diagnosis and Treatment of Lung Cancer: an Evidence-Based Guide for the Practicing Clinician. W. B. Saunders, Philadelphia, PA2001: 437-449
        • Battafarano RJ
        • Force SD
        • Meyers BF
        • et al.
        Benefits of resection for metachronous lung cancer.
        J Thorac Cardiovasc Surg. 2004; 127: 836-842
        • Lee BE
        • Port JL
        • Stiles BM
        • et al.
        TNM stage is the most important determinant of survival in metachronous lung cancer.
        Ann Thorac Surg. 2009; 88: 1100-1105
        • Finley DJ
        • Yoshizawa A
        • Travis W
        • et al.
        Predictors of outcomes after surgical treatment of synchronous primary lung cancers.
        J Thorac Oncol. 2010; 5: 197-205
        • Motoi N
        • Szoke J
        • Riely GJ
        • et al.
        Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis.
        Am J Surg Pathol. 2008; 32: 810-827
        • Russell PA
        • Wainer Z
        • Wright GM
        • Daniels M
        • Conron M
        • Williams RA
        Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
        J Thorac Oncol. 2011; 6: 1496-1504
        • Sica G
        • Yoshizawa A
        • Sima CS
        • et al.
        A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors.
        Am J Surg Pathol. 2010; 34: 1155-1162
        • Warth A
        • Muley T
        • Meister M
        • et al.
        The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
        J Clin Oncol. 2012; 30: 1438-1446
        • Wang X
        • Wang M
        • MacLennan GT
        • et al.
        Evidence for common clonal origin of multifocal lung cancers.
        J Natl Cancer Inst. 2009; 101: 560-570
        • Hiroshima K
        • Toyozaki T
        • Kohno H
        • Ohwada H
        • Fujisawa T
        Synchronous and metachronous lung carcinomas: molecular evidence for multicentricity.
        Pathol Int. 1998; 48: 869-876
        • Huang J
        • Behrens C
        • Wistuba I
        • Gazdar AF
        • Jagirdar J
        Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis.
        Ann Diagn Pathol. 2001; 5: 321-329
        • Dacic SMDP
        • Ionescu DNMD
        • Finkelstein SMD
        • Yousem SA
        Patterns of allelic loss of synchronous adenocarcinomas of the lung.
        Am J Surg Pathol. 2005; 29: 897-902
        • Chang Y-L
        • Wu C-T
        • Lin S-C
        • Hsiao CF
        • Jou YS
        • Lee YC
        Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers.
        Clin Cancer Res. 2007; 13: 52-58
        • Girard ND
        • Deshpande C
        • Lau C
        • et al.
        Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases.
        Am J Surg Pathol. 2009; 33: 1752-1764
        • Girard N
        • Ostrovnaya I
        • Lau C
        • et al.
        Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers.
        Clin Cancer Res. 2009; 15: 5184-5190
        • Silvestri GA
        • Gonzalez AV
        • Jantz MA
        • et al.
        Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
        Chest. 2013; 143: e211S-e250S
        • Jett JR
        • Schild SE
        • Kesler KA
        • Kalemkerian GP
        Treatment of small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
        Chest. 2013; 143: e400S-e419S
        • Asamura H
        • Goya T
        • Koshiishi Y
        • Japanese Joint Committee of Lung Cancer Registry
        • et al.
        A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.
        J Thorac Oncol. 2008; 3: 46-52
        • Sawabata N
        • Miyaoka E
        • Asamura H
        • Japanese Joint Committee for Lung Cancer Registration
        • et al.
        Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade.
        J Thorac Oncol. 2011; 6: 1229-1235
        • Arenberg D
        • American College of Chest Physicians
        Bronchioloalveolar lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
        Chest. 2007; 132: 306S-313S
        • Garfield DH
        • Cadranel JL
        • Wislez M
        • Franklin WA
        • Hirsch FR
        The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases.
        J Thorac Oncol. 2006; 1: 344-359
        • Detterbeck FC
        • Jones DR
        • Funkhouser WK
        Bronchioloalveolar carcinoma.
        in: Detterbeck FC Rivera MP Socinski Jr, MA Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician. W. B. Saunders, Philadelphia, PA2001: 394-407
        • Kakinuma R
        • Ohmatsu H
        • Kaneko M
        • et al.
        Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer.
        J Comput Assist Tomogr. 2004; 28: 17-23
        • Nakata M
        • Sawada S
        • Yamashita M
        • et al.
        Surgical treatments for multiple primary adenocarcinoma of the lung.
        Ann Thorac Surg. 2004; 78: 1194-1199
        • Travis WD
        • Garg K
        • Franklin WA
        • et al.
        Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma.
        J Clin Oncol. 2005; 23: 3279-3287
        • Sakuma Y
        • Matsukuma S
        • Yoshihara M
        • et al.
        Epidermal growth factor receptor gene mutations in atypical adenomatous hyperplasias of the lung.
        Mod Pathol. 2007; 20: 967-973
        • Takashima S
        • Maruyama Y
        • Hasegawa M
        • et al.
        CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern.
        AJR Am J Roentgenol. 2003; 180: 817-826
        • Kitamura H
        • Kameda Y
        • Nakamura N
        • et al.
        Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen.
        Am J Surg Pathol. 1996; 20: 553-562
        • Trousse D
        • Barlesi F
        • Loundou A
        • et al.
        Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management.
        J Thorac Cardiovasc Surg. 2007; 133: 1193-1200
        • Kim HK
        • Choi YS
        • Kim J
        • Shim YM
        • Lee KS
        • Kim K
        Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma.
        J Thorac Oncol. 2010; 5: 206-210
        • Miller RR
        • Nelems B
        • Evans KG
        • Müller NL
        • Ostrow DN
        Glandular neoplasia of the lung. A proposed analogy to colonic tumors.
        Cancer. 1988; 61: 1009-1014
        • Ullmann R
        • Bongiovanni M
        • Halbwedl I
        • et al.
        Is high-grade adenomatous hyperplasia an early bronchioloalveolar adenocarcinoma?.
        J Pathol. 2003; 201: 371-376
        • Wislez M
        • Massiani M-A
        • Milleron B
        • et al.
        Clinical characteristics of pneumonic-type adenocarcinoma of the lung.
        Chest. 2003; 123: 1868-1877
        • Akira M
        • Atagi S
        • Kawahara M
        • Iuchi K
        • Johkoh T
        High-resolution CT findings of diffuse bronchioloalveolar carcinoma in 38 patients.
        AJR Am J Roentgenol. 1999; 173: 1623-1629
        • Park JH
        • Lee KS
        • Kim JH
        • et al.
        Malignant pure pulmonary ground-glass opacity nodules: prognostic implications.
        Korean J Radiol. 2009; 10: 12-20
        • López-Encuentra A
        • Duque-Medina JL
        • Rami-Porta R
        Persistent confusion on the clinical and pathologic nodal staging in lung cancer.
        J Thorac Oncol. 2010; 5: 285-286
        • Rami-Porta R
        • López-Encuentra A
        • Duque-Medina JL
        Caution! The latest AJCC's rules for lung cancer classification differ from the latest UICC's.
        Lung Cancer. 2004; 43: 361-362
        • Detterbeck FC
        Integration of mediastinal staging techniques for lung cancer.
        Semin Thorac Cardiovasc Surg. 2007; 19: 217-224
        • Silvestri G
        • Gould MK
        • Margolis ML
        • et al.
        American College of Chest Physicians. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition).
        Chest. 2007; 132: 178S-201S
        • Detterbeck F
        • Puchalski J
        • Rubinowitz A
        • Cheng D
        Classification of the thoroughness of mediastinal staging of lung cancer.
        Chest. 2010; 137: 436-442
        • Hermanek P
        • Hutter RVP
        • Sobin LH
        • Wittekind C
        International Union Against Cancer. Classification of isolated tumor cells and micrometastasis.
        Cancer. 1999; 86: 2668-2673
        • Osaki T
        • Oyama T
        • Gu C-D
        • et al.
        Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer.
        J Clin Oncol. 2002; 20: 2930-2936
        • Wu J
        • Ohta Y
        • Minato H
        • et al.
        Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter.
        Ann Thorac Surg. 2001; 71: 1772-1777
        • Le Pimpec-Barthes F
        • Danel C
        • Lacave R
        • et al.
        Association of CK19 mRNA detection of occult cancer cells in mediastinal lymph nodes in non-small cell lung carcinoma and high risk of early recurrence.
        Eur J Cancer. 2005; 41: 306-312
        • Nosotti M
        • Falleni M
        • Palleschi A
        • et al.
        Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker.
        Chest. 2005; 128: 1539-1544
        • Maddaus M
        • Wang X
        • Vollmer R
        • et al.
        CALGB 9761: A prospective analysis of IHC and PCR based detection of occult metastatic disease in stage I NSCLC.
        J Clin Oncol, ASCO Annual Proceedings Part I. 2006; 24: 7030
        • Marchevsky AM
        • Qiao J-H
        • Krajisnik S
        • Mirocha JM
        • McKenna RJ
        The prognostic significance of intranodal isolated tumor cells and micrometastases in patients with non-small cell carcinoma of the lung.
        J Thorac Cardiovasc Surg. 2003; 126: 551-557
        • Boffa D
        • Detterbeck F
        • Smith E
        • et al.
        Should the 7th edition of the lung cancer stage classification system change treatment algorithms in NSCLC?.
        J Thorac Oncol. 2010; 5: 1779-1783